compared to 50% in vehicle-treated controls.
There is currently no clinical evidence or human data showing that psilocybin extends human lifespan or slows human aging.
Research suggests that psilocybin and its active metabolite, psilocin, may delay biological aging.
A study published in npj Aging demonstrated that treating human skin and lung fibroblasts with psilocin delayed
replicative senescence and extended cellular lifespan by 29% to 57% in a dose-dependent manner.
Aged female mice (19 months old, roughly equivalent to older human age) receiving monthly oral doses of psilocybin over a 10-month span reached an 80% survival rate
President Donald Trump signs the executive order to make every federal agency merge into https://t.co/3EBrGp3C7a.
https://t.co/3EBrGp3C7a is an AI-powered platform that will be used to access the services of the 47 federal government agencies in one